Orphan drug savings often sit unclaimed inside a hospital's own purchasing data. Many facilities assume every orphan designated drug falls outside 340B pricing, yet that assumption costs real money every quarter. Some drugs qualify through manufacturer discretionary pricing even when the mandatory 340B discount does not apply.
Hospitals that actively track orphan drug savings tend to follow a...
Arabic
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek